Variant report
Variant | esv3425977 |
---|---|
Chromosome Location | chr8:53349999-53352897 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181679240 | chr8:53350008-53350009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141692879 | chr8:53350077-53350078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35045131 | chr8:53350083-53350084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554315600 | chr8:53350097-53350098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186429893 | chr8:53350110-53350111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150496417 | chr8:53350173-53350174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564238341 | chr8:53350175-53350176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs570719366 | chr8:53350194-53350195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376812215 | chr8:53350227-53350228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112304477 | chr8:53350286-53350287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs166928 | chr8:53350287-53350288 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs548906750 | chr8:53350307-53350308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs117061082 | chr8:53350364-53350365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76793061 | chr8:53350399-53350400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72614653 | chr8:53350422-53350423 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs376273642 | chr8:53350430-53350431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368099926 | chr8:53350468-53350469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577301125 | chr8:53350478-53350479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139466655 | chr8:53350498-53350499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556093112 | chr8:53350507-53350508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574502875 | chr8:53350561-53350562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149255511 | chr8:53350564-53350565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs11994781 | chr8:53350566-53350567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190879624 | chr8:53350581-53350582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546016170 | chr8:53350594-53350595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372294493 | chr8:53350610-53350611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112075935 | chr8:53350645-53350646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147430315 | chr8:53350656-53350657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543544053 | chr8:53350657-53350658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561624437 | chr8:53350672-53350673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555490639 | chr8:53350782-53350783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548896564 | chr8:53350823-53350824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375609412 | chr8:53350840-53350841 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527865424 | chr8:53350867-53350868 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76083720 | chr8:53350880-53350881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77481561 | chr8:53350881-53350882 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs16917841 | chr8:53350893-53350894 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs537871080 | chr8:53350921-53350922 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113116087 | chr8:53350939-53350940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139795349 | chr8:53350975-53350976 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35781846 | chr8:53351001-53351002 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs374203349 | chr8:53351033-53351034 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369739154 | chr8:53351045-53351046 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs180854477 | chr8:53351060-53351061 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568110552 | chr8:53351098-53351099 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs284800 | chr8:53351137-53351138 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs553769205 | chr8:53351141-53351142 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs199965891 | chr8:53351146-53351147 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201133277 | chr8:53351147-53351148 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs375621265 | chr8:53351148-53351149 | Flanking Active TSS Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:53344600-53351000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
2 | chr8:53350800-53351000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr8:53351000-53351200 | Flanking Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr8:53351000-53351200 | Enhancers | Gastric | stomach |
5 | chr8:53351000-53351600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr8:53351000-53351600 | Enhancers | Fetal Kidney | kidney |
7 | chr8:53351000-53352400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr8:53351000-53352800 | Strong transcription | Primary hematopoietic stem cells short term culture | blood |
9 | chr8:53351200-53351400 | Flanking Active TSS | Gastric | stomach |
10 | chr8:53351200-53351400 | Enhancers | Pancreas | Pancrea |
11 | chr8:53351200-53351600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr8:53351200-53351600 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
13 | chr8:53351200-53351800 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr8:53351200-53352400 | Enhancers | Spleen | Spleen |
15 | chr8:53351200-53352800 | Enhancers | Esophagus | oesophagus |
16 | chr8:53351400-53351800 | Active TSS | Gastric | stomach |
17 | chr8:53351400-53352000 | ZNF genes & repeats | Pancreas | Pancrea |
18 | chr8:53351600-53351800 | Flanking Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr8:53351600-53351800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr8:53351600-53351800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
21 | chr8:53351800-53352000 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
22 | chr8:53352000-53352200 | Weak transcription | Pancreas | Pancrea |
23 | chr8:53352800-53360000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |